A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1991-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.88.21.9633PMID 1719536PMCID PMC52772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

  1991cited by this paper
• Peripheral selection of the T cell repertoire.

  1991cited by this paper
• Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

  1991cited by this paper
• Myosin-induced acute myocarditis is a T cell-mediated disease.

  1991cited by this paper
• A cell culture model for T lymphocyte clonal anergy.

  1990cited by this paper
• Immunological activity of covalently linked T-cell epitopes

  1990cited by this paper
• Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice

  1990cited by this paper
• In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B

  1990cited by this paper
• Self-nonself discrimination by T cells.

  1990cited by this paper
• T cell reactivity to MHC molecules: immunity versus tolerance.

  1990cited by this paper
• Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells.

  1990cited by this paper
• Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance.

  1990cited by this paper
• The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo.

  1990cited by this paper
• Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants.

  1990cited by this paper
• Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.

  1990cited by this paper
• Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

  1990cited by this paper
• Peptide competition for antigen presentation.

  1990cited by this paper
• The role of the T cell receptor in positive and negative selection of developing T cells.

  1990cited by this paper
• Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.

  1989cited by this paper
• Activation-driven programmed cell death and T cell receptor zeta eta expression.

  1989cited by this paper
• Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

  1989cited by this paper
• Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.

  1988cited by this paper
• Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells

  1988cited by this paper
• Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma

  1988cited by this paper
• Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

  1988cited by this paper
• Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein.

  1988cited by this paper
• A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis

  1988cited by this paper
• Major histocompatibility complex-linked control of the murine immune response to myelin basic protein.

  1985cited by this paper
• Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker.

  1985cited by this paper
• T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination

  1985cited by this paper
• Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.

  1984cited by this paper
• Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

  1981cited by this paper
• Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE.

  1979cited by this paper
• Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

  1977cited by this paper

• Autoantigen and IL-2 activated CD4+CD25+T regulatory cells are induced to express CD8 and are autoantigen specific in inhibiting experimental autoimmune encephalomyelitis.

  2025cites this paper
• Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders

  2024cites this paper
• A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models.

  2024cites this paper
• Small Extracellular Vesicles Derived from Altered Peptide Ligand‐Loaded Dendritic Cell Act as A Therapeutic Vaccine for Spinal Cord Injury Through Eliciting CD4+ T cell‐Mediated Neuroprotective Immunity

  2023cites this paper
• Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future

  2021cites this paper
• Emerging Biological and Molecular Therapies in Autoimmune Disease

  2020cites this paper
• MHC Class II tetramers and the pursuit of antigen-specific T cells : define , deviate

  2019influential citation
• Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects

  2019cites this paper
• A Modified Peptide Derived from Goodpasture Autoantigen Arrested and Attenuated Kidney Injuries in a Rat Model of Anti-GBM Glomerulonephritis.

  2019cites this paper
• The Effect of a Tropical Climate on Available Nutrient Resources to Springs in Ophiolite-Hosted, Deep Biosphere Ecosystems in the Philippines

  2017cites this paper
• A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis

  2017cites this paper
• Comparison of antibody responses against Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the endemic and non-endemic regions of the Beijing genotype: a case control study

  2017cites this paper
• MULTIMERIC FORMS OF HUMAN RHINOVIRUS RECEPTOR AND FRAGMENTS THEREOF

  2017cites this paper
• Roles of regulatory T cells and IL-10 in virus-induced demyelination

  2017cites this paper
• T cells in the control of organ-specific autoimmunity.

  2015cites this paper
• Restoring the balance: immunotherapeutic combinations for autoimmune disease

  2014cites this paper
• Chapter 10 – Autoimmunity

  2014cites this paper
• A modified superantigen rescues Ly6G− CD11b+ blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE

  2013cites this paper
• The Involvement of Calpain in CD4+ T Helper Cell Bias in Multple Sclerosis

  2013cites this paper
• Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

  2013cites this paper
• Homology, similarity, and identity in peptide epitope immunodefinition

  2012cites this paper
• Therapeutic Approaches in Multiple Sclerosis

  2012cites this paper
• IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.

  2012cites this paper
• (E)-alkene and ethylene isosteres substantially alter the hydrogen-bonding network in class II MHC A(q)/glycopeptide complexes and affect T-cell recognition.

  2011cites this paper
• Altered Differentiation, Diminished Pathogenicity, and Regulatory Activity of Myelin-Specific T Cells Expressing an Enhanced Affinity TCR

  2011cites this paper
• Enhanced Affinity TCR Myelin-Specific T Cells Expressing an Pathogenicity , and Regulatory Activity of Altered Differentiation , Diminished

  2011cites this paper
• Lessons from the Past and Future Approaches for Immunologic Therapies in Multiple Sclerosis

  2010cites this paper
• Manipulating Antigenic Ligand Strength to Selectively Target Myelin-Reactive CD4+ T Cells in EAE

  2010cites this paper
• A Comparative Approach Linking Molecular Dynamics of Altered Peptide Ligands and MHC with In Vivo Immune Responses

  2010cites this paper
• VACCINE PLATFORM FOR INFECTION OR AUTOIMMUNE DISEASES USING AN ETEC FIMBRIAL SCAFFOLD

  2009cites this paper
• The Use of Myeloid Suppressor Cells to  Inhibit Experimental Autoimmune  Encephalomyelitis: a Potential  Immunotherapy for Multiple Sclerosis

  2009cites this paper
• A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.

  2008cites this paper
• The good, the bad and the ugly: how altered peptide ligands modulate immunity

  2008influential citation
• The good, the bad and the ugly: how altered peptide ligands modulate immunity.

  2008cites this paper
• Analysis of Myelin-Reactive T Lymphocyte Function in Models of Multiple Sclerosis

  2008cites this paper
• An altered peptide ligand of type II collagen suppresses autoimmune arthritis.

  2007cites this paper
• Multiple-Sklerose-Update zur Pathophysiologie und neuen immuntherapeutischen Ansätzen

  2007cites this paper
• Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry.

  2007cites this paper
• Review of Novel Immunotherapeutic Strategies for MS

  2007cites this paper
• Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.

  2007cites this paper
• Analysis of antigen reactive T-cells.

  2007cites this paper
• [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

  2007cites this paper
• Probing molecular interactions within class II MHC Aq/glycopeptide/T-cell receptor complexes associated with collagen-induced arthritis.

  2007cites this paper
• A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.

  2006cites this paper
• The MHC-glycopeptide-T cell interaction in collagen induced arthritis : a study using glycopeptides, isosteres and statistical molecular design in a mouse model for rheumatoid arthritis

  2006cites this paper
• Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: the role of positions 91 and 96 in T-cell receptor activation.

  2006cites this paper
• Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.

  2005cites this paper
• Immunomodulation of EAE: Altered Peptide Ligands, Tolerance, and Th1/Th2

  2005cites this paper
• Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and Peptides

  2005cites this paper
• Chapter 2 – MHC Class II

  2005cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2005cites this paper
• Therapeutic alteration of T cell development: Modulating diabetogenic and regulatory T cells in the treatment of type 1 diabetes mellitus

  2005cites this paper
• VaccineBias and Acts as an Anti-Inflammatory A Live Diarrheal Vaccine Imprints a Th2 Cell

  2005cites this paper
• Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.

  2005cites this paper
• Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3.

  2005cites this paper
• A Live Diarrheal Vaccine Imprints a Th2 Cell Bias and Acts as an Anti-Inflammatory Vaccine1

  2005cites this paper
• Approaches toward peptide-based immunotherapy of autoimmune diseases

  2004cites this paper
• MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, delete.

  2004influential citation
• Immunotherapy for multiple sclerosis: basic insights for new clinical strategies.

  2004cites this paper
• Experimental immunotherapies for multiple sclerosis

  2004cites this paper
• A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease

  2004cites this paper
• Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex

  2002cites this paper
• Aspects of the Immunobiology of Myelin Oligodendrocyte Glycoprotein (MOG)-induced Experimental Autoimmune Encephalomyelitis (EAE)

  2002cites this paper
• Selection and fine-tuning of the autoimmune T-cell repertoire

  2002cites this paper
• Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

  2002cites this paper
• Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse.

  2002cites this paper
• Peptide‐based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities

  2001cites this paper
• Tolerance induction by acylated peptides: suppression of EAE in the mouse with palmitoylated PLP peptides.

  2001influential citation
• Negative Selection during the Peripheral Immune Response to Antigen

  2001cites this paper
• Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease.

  2001cites this paper
• Perspektiven der klinischen Multiple-Sklerose-Forschung und -Therapie

  2001cites this paper
• Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation.

  2001cites this paper
• Tolerance induction in indirect alloresponses by analogs of HLA-derived peptides.

  2001cites this paper
• Identification of alloreactive T-cell epitopes on the Rhesus D protein.

  2000cites this paper
• Mechanisms of Neonatal Tolerance Induced in an Animal Model for Primary Sjögren's Syndrome by Intravenous Administration of Autoantigen

  2000cites this paper
• T‐cell regulation of peripheral tolerance and immunity: the potential role for
 Notch signalling

  2000cites this paper
• Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.

  2000cites this paper
• T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase.

  2000cites this paper
• IDENTIFICATION OF ALLOREACTIVE T-CELL EPITOPES ON THE RHESUS D PROTEIN

  2000cites this paper
• PEPTIDE ANALOGUES AS A STRATEGY TO INDUCE TOLERANCE IN T CELLS WITH INDIRECT ALLOSPECIFICITY1

  2000cites this paper
• Despite epitope spreading in the pathogenesis of autoimmune disease, highly restricted approaches to immune therapy may still succeed [with a hedge on this bet].

  2000cites this paper
• Prevention of experimental autoimmune encephalomyelitis by encephalitogenic epitope sequence simplified derivatives.

  2000cites this paper
• pH stability of HLA-DR4 complexes with antigenic peptides.

  2000cites this paper
• Redirecting Th1 and Th2 responses in autoimmune disease.

  1999cites this paper
• Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide.

  1999cites this paper
• Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.

  1999cites this paper
• Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.

  1999cites this paper
• A small number of residues in the class II molecule I-Au confer the ability to bind the myelin basic protein peptide Ac1-11.

  1999cites this paper
• Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.

  1999cites this paper
• Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease.

  1999cites this paper
• Makes the Difference One-Amino Acid Change in the B Chain Insulin in Oral Immune ' ' Tolerance ' ' : A

  1999cites this paper
• TCR Transgenic Mice Autoimmune Encephalomyelitis Induction in Microbial Peptides : Experimental Protein-Specific T Cells with Multiple Cross-Reactivity of Myelin Basic

  1999cites this paper
• Cell-Mediated Parasitic Disease Immunodominant Peptide Associated with T Elucidation and Role of Critical Residues of

  1999cites this paper
• Tolerance induction by acylated peptides: effect on encephalitogenic T cell lines.

  1999cites this paper
• Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism.

  1999cites this paper
• Antagonistic activity of HIV‐1 T helper peptides flanked by an unrelated carrier protein

  1999cites this paper
• Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference.

  1999cites this paper
• Identifying the autoantigen of a diabetogenic CD8 T cell clone isolated from young NOD mice

  1999cites this paper
• Effects of peptide therapy on ex vivo T-cell responses.

  1998cites this paper
• The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity

  1998cites this paper